A Treatment for Monkeypox?

Monkeypox is the newest worldwide pandemic and closely mirrors both COVID-19 and HIV pandemics. A large difference is theoretical vaccines and treatments for monkeypox already exist. In this episode of GameChangers, host Geoff Wall, evaluates tecovirimat, a potential monkeypox treatment and the regulations that made it possible.The GameChanger Little to no randomized controlled data exist on tecovirimat’s safety and efficacy in monkeypox. A recent case series helps establish the safety of tecovirimat for monkeypox use.Show Segments 00:00 - Introductions02:40 - Current Issue of Monkeypox04:02 - Tecovirimat “Animal Rule”11:19 - The GameChanger: Tecovirimat Case Series17:20 - Applying to Practice20:45 - Closing RemarksHost Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health References and resources:Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection.Redeem your CPE or CME creditCPE (Pharmacist)CME (Physician)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a Membership Prescribers: Get a Membership Continuing Education Information:Learning Objectives:1. Describe the development and use of tecovirimat under the “Animal Rule”2. Discuss the latest report of tecovirimat use in US patients with monkeypoxAll relevant financial relationships have been mitigated.  0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-22-354-H01-PInitial release date: 09/26/22Expiration date: 09/26/2023Additional CPE & CME details can be found here Follow CEimpact on Social Media:LinkedInInstagram